Xromi clinical trials

PASS of Xromi Comparing Safety and Effectiveness in Children Under 2 Years With Sickle Cell Disease [PRECISE PASS]

This study looks at how safe and effective a medicine called Xromi is for very young children (under 2) with sickle cell disease. It compares children taking Xromi to similar children who are not, to see how it helps and if there are any side effects.